PDF(Pubmed)
Abstract：
UNASSIGNED: Patients undergoing surgery, particularly patients undergoing surgery for oncology diagnoses, experience anxiety. Surgery remains the primary treatment for many common types of cancer. One promising potential intervention to alleviate anxiety in the preoperative and postoperative period is meditation, an integrative medicine intervention. However, there remains a gap in the literature regarding the effectiveness of meditation to alleviate anxiety during the perioperative time period.
UNASSIGNED: The scoping review was conducted using the Arksey and O\'Malley framework to synthesize the study findings and was reported with the Preferred Reporting Items for Systematic reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). The review included EMBASE, PubMed, Web of Science, CINAHL Plus, Scopus, and Cochrane Review databases from 2013 through 2024. All identified articles were exported to the online systematic review software, Covidence.
UNASSIGNED: A total of 538 initial citations were identified, 415 titles and abstracts were screened, and 83 full-text articles reviewed. Six studies were finally included. The data extracted from the literature included: study purpose, study design, sample size, preoperative or postoperative timeframe, instrument to evaluate anxiety, and conclusions.
UNASSIGNED: For patients undergoing oncology surgery, the perioperative period can be filled with anxiety. Guided, mindfulness, and loving-kindness meditation may be helpful in reducing anxiety, particularly in patients undergoing surgery for breast cancer during the postoperative period. However, the current literature is extremely limited. Future research should expand on the preliminary effectiveness to broader populations and carefully target the highest-risk populations for the ideal time point for interventions.
UNASSIGNED: The scoping review was conducted using the Arksey and O\'Malley framework to synthesize the study findings and was reported with the Preferred Reporting Items for Systematic reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). The review included EMBASE, PubMed, Web of Science, CINAHL Plus, Scopus, and Cochrane Review databases from 2013 through 2024. All identified articles were exported to the online systematic review software, Covidence.
UNASSIGNED: A total of 538 initial citations were identified, 415 titles and abstracts were screened, and 83 full-text articles reviewed. Six studies were finally included. The data extracted from the literature included: study purpose, study design, sample size, preoperative or postoperative timeframe, instrument to evaluate anxiety, and conclusions.
UNASSIGNED: For patients undergoing oncology surgery, the perioperative period can be filled with anxiety. Guided, mindfulness, and loving-kindness meditation may be helpful in reducing anxiety, particularly in patients undergoing surgery for breast cancer during the postoperative period. However, the current literature is extremely limited. Future research should expand on the preliminary effectiveness to broader populations and carefully target the highest-risk populations for the ideal time point for interventions.
摘要：
■接受手术的患者，特别是接受肿瘤诊断手术的患者，体验焦虑。手术仍然是许多常见类型癌症的主要治疗方法。在术前和术后缓解焦虑的一个有希望的潜在干预措施是冥想，综合医学干预。然而,在围手术期冥想缓解焦虑的有效性方面,文献仍存在空白.
■范围审查是使用Arksey和O\'Malley框架进行的，以综合研究结果，并与系统审查的首选报告项目和范围审查的Meta分析扩展（PRISMA-ScR）一起报告。审查包括EMBASE，PubMed,WebofScience,CINAHLPlus,Scopus,和2013年至2024年的CochraneReview数据库。所有已识别的文章都输出到在线系统审查软件，Covidence.
■总共确定了538篇初始引文，筛选了415个标题和摘要，审查了83篇全文。最终纳入了六项研究。从文献中提取的数据包括：研究目的，研究设计，样本量,术前或术后时间范围，评估焦虑的工具，和结论。
■对于接受肿瘤外科手术的患者，围手术期可以充满焦虑。引导,正念,慈爱冥想可能有助于减少焦虑，特别是在术后接受乳腺癌手术的患者中。然而,目前的文献极为有限。未来的研究应将初步有效性扩展到更广泛的人群，并仔细针对最高风险人群的理想干预时间点。
■范围审查是使用Arksey和O\'Malley框架进行的，以综合研究结果，并与系统审查的首选报告项目和范围审查的Meta分析扩展（PRISMA-ScR）一起报告。审查包括EMBASE，PubMed,WebofScience,CINAHLPlus,Scopus,和2013年至2024年的CochraneReview数据库。所有已识别的文章都输出到在线系统审查软件，Covidence.
■总共确定了538篇初始引文，筛选了415个标题和摘要，审查了83篇全文。最终纳入了六项研究。从文献中提取的数据包括：研究目的，研究设计，样本量,术前或术后时间范围，评估焦虑的工具，和结论。
■对于接受肿瘤外科手术的患者，围手术期可以充满焦虑。引导,正念,慈爱冥想可能有助于减少焦虑，特别是在术后接受乳腺癌手术的患者中。然而,目前的文献极为有限。未来的研究应将初步有效性扩展到更广泛的人群，并仔细针对最高风险人群的理想干预时间点。
